The Asia Pacific Organ Preservation Market size was valued at USD 44.56 million in 2022 and is expected to grow at a CAGR of 6.5% and worth USD 61.05 million by 2027.
DRIVERS
The number of cases of organ failure caused by various health conditions, such as severe diabetes, is increasing rapidly around the world. This has resulted in a sharp increase in the number of organ transplants. As a result, the demand for organ preservation has also increased worldwide. Despite a large gap between organ supply and demand, there are many programs being implemented to promote organ donation in order to meet the growing demand for organ transplants, which will likely contribute to the growth of the APAC organ preservation market during the forecast period.
Due to various advancements in the field of organ transplantation and preservation, the APAC organ preservation market is estimated to grow during the forecast period with a healthy CAGR. Advances in conservation technologies and techniques have also increased the accessibility of organs in remote areas. In addition, with the technological advances in the medical field, the success rates of organ transplants are increasing, so that more and more people are opting for such a transplant.
RESTRAINTS
Organ transplant surgery is one of the most expensive in the healthcare. This is because the number of donations is far less than the demand for organ transplants, which creates a huge demand and supply gap. Due to this gap, obtaining an organ is a difficult task, which results in a hike in the prices of organs in black market sales. The sharp decline in organ donations also exacerbates the dearth of transplantable organs and the need for organ transplants. Furthermore, transplant surgeries are very expensive, which is a major hindrance to the growth of the organ preservation market.
OPPORTUNITIES
Technological advancements such as use of Artificial intelligence and robots are providing better opportunities for the market growth.
CHALLENGES
The Covid-19 pandemic has had a significant detrimental impact on the APAC organ preservation market. As the number of Covid-19 cases have increased, all non-essential and elective surgical procedures are immediately postponed. As a result, the need for organ preservation has reduced. These surgeries also involves the utilization of ICUs and medical ventilators, which were prioritized for use for Covid-19 critical treatment cases. Furthermore, allowing organ transplant procedures in the presence of highly communicable virus is not advised. Therefore, the most surgeries were postponed, this resulted in the decrease in the demand for organ preservation.
This research report on the Asia Pacific Organ Preservation Market has been segmented and sub-segmented into the following categories:
By Preservation Solution:
By Transportation Technique:
By Organ Type:
By Country:
REGIONAL ANALYSIS
The fastest growth in APAC market is attributed to the rising population, improved the standard of living, increasing healthcare spending and demand for new and innovative treatment options.
China has an increasing geriatric population with organ failure cases, favorable reimbursement policies, and increasing burden of diabetes, cardiovascular disorder, diabetic nephropathy, and obesity would positively impact market growth in the coming years.
Japan is highly advanced in the practice of organ preservation. Thus, it holds the considerable share in the APAC organ preservation market. For instance, by the end of 2016, there were 32 facilities, performing transplants, which successful track record of kidney transplantation. Pacific regions will also have healthy growth rate due to awareness and advanced healthcare facilities in upcoming years.
KEY MARKET PLAYERS:
Some notable companies operating in the Asia Pacific Organ Preservation Market profiled in the report are Essential Pharmaceuticals, Dr. Franz Kohler Chemie GmbH, Organ Recovery Systems, Xvivo Perfusion AB, and Waters Medical Systems LLC.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Technique
5.1.1 Introduction
5.1.2 Static Cold Storage (SCS) Technique
5.1.3 Hypothermic Machine Perfusion
5.1.4 Normothermic Machine Perfusion
5.1.5 Y-o-Y Growth Analysis, By Technique
5.1.6 Market Attractiveness Analysis, By Technique
5.1.7 Market Share Analysis, By Technique
5.2 Preservation Technique
5.2.1 Introduction
5.2.2 University of Wisconsin Solution (UW Solution)
5.2.3 Custodiol HTK
5.2.4 Perfadex
5.2.5 Other Preservation Solutions
5.2.6 Y-o-Y Growth Analysis, By Preservation Technique
5.2.7 Market Attractiveness Analysis, By Preservation Technique
5.2.8 Market Share Analysis, By Preservation Technique
5.3 Organ Type
5.3.1 Introduction
5.3.2 Kidneys
5.3.3 Liver
5.3.4 Lung
5.3.5 Heart
5.3.6 Other Organs (Pancreas, Intestine)
5.3.7 Y-o-Y Growth Analysis, By Organ Type
5.3.8 Market Attractiveness Analysis, By Organ Type
5.3.9 Market Share Analysis, By Organ Type
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Technique
6.1.3.3 By Preservation Technique
6.1.3.4 By Organ Type
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Technique
6.1.4.3 By Preservation Technique
6.1.4.4 By Organ Type
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Technique
6.1.5.3 By Preservation Technique
6.1.5.4 By Organ Type
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Waters Medical Systems LLC [Institut Georges Lopez (IGL]
8.1.1 Overview
8.1.2 Technique Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Bridge to Life Limited
8.3 Organox Limited
8.4 Transmedics, Inc.
8.5 Xvivo Perfusion AB
8.6 Preservation Solutions, Inc.
8.7 Lifeline Scientific, Inc. (Organ Recovery Systems, Inc.)
8.8 Essential Pharmaceuticals, LLC
8.9 Dr. Franz Kohler Chemie GmbH
8.10 21st Century Medicine Inc.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.
